Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02077933
Title Study of Safety and Efficacy of BYL719 With Everolimus or BYL719 With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | ITA | HUN | GBR | FRA | ESP | DEU

Facility Status City State Zip Country Details
Highlands Oncology Group Fayetteville Arkansas 72703 United States Details
Memorial Sloan Kettering Cancer Center SC - BYL719Z2102 New York New York 10065 United States Details
Novartis Investigative Site Bordeaux Cedex 33075 France Details
Novartis Investigative Site Bordeaux 33076 France Details
Novartis Investigative Site Paris 75970 France Details
Novartis Investigative Site Villejuif Cedex 94805 France Details
Novartis Investigative Site Berlin 13353 Germany Details
Novartis Investigative Site Essen 45136 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Hannover 30625 Germany Details
Novartis Investigative Site Hong Kong Hong Kong Details
Novartis Investigative Site Budapest H-1077 Hungary Details
Novartis Investigative Site Ancona AN 60126 Italy Details
Novartis Investigative Site Milano MI 20141 Italy Details
Novartis Investigative Site Modena MO 41124 Italy Details
Novartis Investigative Site Verona VR 37126 Italy Details
Novartis Investigative Site Amsterdam 1066 CX Netherlands Details
Novartis Investigative Site Utrecht 3584CX Netherlands Details
Novartis Investigative Site Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field